Seminars in Hematology
Volume 41, Issue 2 , Pages 118-141, April 2004

Hereditary spherocytosis—defects in proteins that connect the membrane skeleton to the lipid bilayer

  • Stefan Eber

      Affiliations

    • Division of Hematology/Oncology, Children’s Hospital Boston, Boston, MA, USA
    • Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    • Corresponding Author InformationAddress correspondence to Professor Dr Stefan Eber, Childrens Hospital of the Technical University, Koelner Place 1, D80804 Munich, Germany
  • ,
  • Samuel E Lux

      Affiliations

    • Division of Hematology/Oncology, Children’s Hospital Boston, Boston, MA, USA
    • Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Abstract 

The molecular causes of hereditary spherocytosis (HS) have been unraveled in the past decade. No frequent defect is found, and nearly every family has a unique mutation. In dominant HS, nonsense and frameshift mutations of ankyrin, band 3, and β-spectrin predominate. Recessive HS is most often due to compound heterozygosity of defects in ankyrin, α-spectrin, or protein 4.2. Common combinations include a defect in the promoter or 5′-untranslated region of ankyrin paired with a missense mutation, a low expression allele of α-spectrin plus a missense mutation, and various mutations in the gene for protein 4.2. In most patients’ red cells, no abnormal protein is present. Only rare missense mutations, like ankyrin Walsrode (V463I) or β-spectrin Kissimmee (W202R), have given any insight into the functional domains of the respective proteins. Although the eminent role of the spleen in the premature hemolysis of red cells in HS is unquestioned, the molecular events that cause splenic conditioning of spherocytes are unclear. Electron micrographs show that small membrane vesicles are shed during the formation of spherocytes. Animal models give further insight into the pathogenetic consequences of membrane protein defects as well as the causes of the variability of disease severity.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 S.E. is supported by the Deutsche Forschungsgemeinschaft (DFG 99/6–1+2). S.E.L. is supported by Grants No. R01 DK34083 and P01 HL32262 from the National Institutes of Health.

PII: S0037-1963(04)00003-4

doi:10.1053/j.seminhematol.2004.01.002

Seminars in Hematology
Volume 41, Issue 2 , Pages 118-141, April 2004